摘要
新型冠状病毒肺炎的爆发严重危害了人们的身体健康和生命安全。国家卫生健康委员会发布的《新型冠状病毒肺炎诊疗方案(试行第七版)》(以下简称第七版方案)中,推荐临床治疗期重型、危重型患者在使用中药饮片的同时可联合使用中药注射剂。本文针对第七版方案中推荐的部分中药注射剂,详细分析其相关作用特点及药学监护点,帮助临床医护人员合理使用中药注射剂,以利于中医药防治新型冠状病毒肺炎疫情,促进临床一线合理用药。
The outbreak of COVID-19 endangered people’s health and safety seriously.Diagnosis and Treatment Program for COVID-19(trial version 7)(hereinafter referred to as the seventh version program)released by the National Health Commission of the People’s Republic of China recommended that patients with severe or critical COVID-19 could use traditional Chinese medicine injection combined with traditional Chinese medicine decoction during the clinical treatment period.According to the recommendation of traditional Chinese medicine injection from the seventh version program,this paper analyzes the relevant characteristics and pharmaceutical care points in detail and helps the clinical medical staff to use traditional Chinese medicine injection reasonably,which is conducive to the prevention and treatment of COVID-19 and the promotion of the first-line rational drug use in clinical practice.
作者
庄红艳
王艳梅
朱虹
房萌
刘杰
赵爽
李雪
薛春苗
ZHUANG Hongyan;WANG Yanmei;ZHU Hong;FANG Meng;LIU Jie;ZHAO Shuang;LI Xue;XUE Chunmiao(Dept. of Pharmacy, Beijing Anding Hospital, Capital Medical University, the National Clinical Research Center for Mental Disorders, Beijing Key Laboratory of Mental Disorders, Beijing 100088, China;Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, China;Dept. of Pharmacy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China)
出处
《中国医院用药评价与分析》
2020年第4期385-388,共4页
Evaluation and Analysis of Drug-use in Hospitals of China
基金
国家自然基金面上项目(No.81873398)
首都卫生发展科研专项项目(No.首发2018-4-2124)
首都卫生发展科研专项重点攻关项目(No.首发2018-1-2122)
北京中医药科技发展资金项目(No.JJ2018-42)
北京市医院管理中心“登峰”计划专项经费(No.DFL20191901)。
关键词
中药注射剂
新型冠状病毒肺炎
药学监护
合理用药
Traditional Chinese medicine injection
COVID-19
Pharmaceutical care
Rational use of drugs
